Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
SIGMA HEALTHCARE LIMITED (SIG)ASX AI Signals has generated 4 signal for SIG during the last 90 days, indicating active trading activity and ongoing AI monitoring
Latest SIG Signals | |
| 11/06/2026 | SELL |
| 01/06/2026 | BUY |
| 31/05/2026 | BUY |
SIG Share Price | |
| Current Price | $2.790 |
| 52 Week High | $3.137 |
| 52 Week Low: | $2.600 |
| Trading at (% of 52 Week High) | 88.94% |
Sigma Healthcare Limited (ASX: SIG) is an Australian pharmaceutical company that supplies prescription medicines, over-the-counter healthcare products, and pharmacy services. It operates a network of community pharmacies and provides wholesale distribution across Australia.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
The SELL recommendation for SIGMA HEALTHCARE LIMITED is supported by recent downward price momentum and sector-specific challenges. However, moderate market volatility and potential for short-term rebounds temper the confidence to a high rather than very high level.
This article first appeared on GuruFocus.
Sigma Healthcare (SIGGF) has pulled out of the Boots sale process, stepping away from a potential acquisition of the British pharmacy chain that could have been worth as much as $10 billion. The Australian owner of Chemist Warehouse said the process initial Australia-based Sigma Healthcare has withdrawn from discussions over a possible acquisition of UK pharmacy chain Boots, saying a deal valued at $10bn would not align with its strategy.
The company, which owns Chemist Warehouse and runs a pharmaceutical wholesale business, confirmed to the Financial Sigma’s decision to pull out of talks places further uncertainty on Boots’s future - Mike Kemp
The Australian pharmacy group Sigma Healthcare has dropped out of talks for a potential takeover of Boots, a deal that would have valued the British retailer at an estimated $10bn (ÂŁ7bn).
Sigma, which wa Australian pharmacy business Sigma Healthcare has pulled out of takeover talks to buy Boots.
The UK beauty and pharmacy giant revealed last week that it had held early discussions over a potential takeover deal.
However, on Monday, bosses at Sigma said the company has “elected to withdraw its inte Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.
If you are wondering whether Sigma Healthcare at A$2.69 is offering fair value or an appealing entry point, a good starting point is to understand what the current market price is realLatest SIGMA HEALTHCARE LIMITED(SIG) News
Sigma Exits $10 Billion Boots Deal Talks
Sigma ends Boots takeover discussions over strategic fit
Australian pharma giant abandons Boots takeover talks
Sigma Healthcare pulls out of Boots takeover talks
Is Sigma Healthcare (ASX:SIG) Now Fairly Priced After Recent Share Price Weakness?
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial